Mulpleta (lusutrombopag) / Shionogi  >>  Phase 2
Welcome,         Profile    Billing    Logout  

3 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Mulpleta (lusutrombopag) / Shionogi
NCT01054443 / 2009-016950-42: A Study to Investigate the Efficacy and Safety of Lusutrombopag (S-888711) Tablets Administered to Adults With Immune Thrombocytopenia (ITP)

Terminated
2
20
US
Placebo, Lusutrombopag, MULPLETA®, S-888711
Shionogi
Immune Thrombocytopenia (ITP)
11/10
11/10
NCT01129024 / 2009-017942-30: An Open-label Safety Study of Lusutrombopag (S-888711) in Adults With Chronic Immune Thrombocytopenia (ITP)

Terminated
2
19
US
Lusutrombopag, MULPLETA®, S-888711
Shionogi
Immune Thrombocytopenia
06/11
06/11
NCT06287567: Lusutrombopag in the Treatment of Immune Thrombocytopenia (ITP)

Recruiting
2
17
RoW
Lusutrombopag Oral Tablet, MULPLETA®, S-888711
Institute of Hematology & Blood Diseases Hospital, China
Idiopathic Thrombocytopenic Purpura, Immune Thrombocytopenia
09/24
11/24

Download Options